Back to All Peptides

Vesilute

Khavinson-series peptide for bladder/urinary tissue — limited evidence.

Limited evidenceLittle or no published human or animal research. Claims rest on theory, traditional use, or anecdote — treat with particular caution.

For research purposes only. These products are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm these products will be used for legitimate research purposes.

About Vesilute

Vesilute is a synthetic short peptide from the Khavinson 'bioregulator' series, proposed to act on the bladder and lower urinary tract. The tissue-specific bioregulator concept — that short peptides normalize protein synthesis in a target organ — is a research hypothesis, not an established mechanism. Compound-specific published research is scarce: Vesilute is described mainly within the broader bioregulator literature rather than in dedicated trials, so its effects in humans are unverified. It is not approved by any regulator and is sold for research use only.

Key Benefits

  • Proposed to act on bladder/urinary tissue (hypothesis-stage)
  • Part of the Khavinson tissue-specific peptide series
  • Little compound-specific published evidence
  • Effects not demonstrated in controlled human trials

Set a goal (top of the page) to see how Vesilute scores against it, and what the better-evidenced alternatives are.

Category Ratings

Muscle & Strength
N/A
Fat Loss
N/A
Recovery
N/A
Skin & Anti-Aging
N/A
Sleep
N/A
Cognitive
N/A
Immune
N/A
Longevity
Minimal
Bone & Hormonal
N/A

How to Take

Injection

Subcutaneous injection, morning or evening

Common Side Effects

  • No formal independent human safety data
  • Originating group reports low toxicity in studies
  • Injection-site reactions (typical of subcutaneous peptides)

Legal & Regulatory Status

Research use only. Not approved by the FDA or EMA for human use. Compound-specific evidence is scarce and concentrated in a single research lineage.

Safety and regulatory details for FDA-approved compounds are drawn from the official product label via openFDA; clinical development status reflects ClinicalTrials.gov. This information is provided for research reference, is not endorsed by the FDA, and may not be complete or current.

Research & Sources

Limited evidenceLittle or no published human or animal research. Claims rest on theory, traditional use, or anecdote — treat with particular caution.

Sources are selected for reliability (peer-reviewed literature, openFDA, ClinicalTrials.gov) but this is a research summary, not medical advice, and may not be exhaustive.

Indicative price

~$59.99

per 20mg vial · reference estimate

Not sold here — Peptide Concierge is an information resource, not a vendor. Prices are research-market references to help you gauge cost.

CategoryBioregulator
Formsinjectable

Builds a working set shared across the stack builder, calculator, scheduler and compare.